N,N'-(2-Chloro-1,4-phenylene)diacetamide, 95.0%, 5g

3-(p-Tolyl)prop-2-yn-1-ol, 95%, 5g

(Z)-Methyl 3-(((4-(methylamino)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylate (Nintedanib Impurity), 97%, 50mg

3-(4-Chlorophenyl)propionaldehyde, 95.0%, 100mg

DBCO-NHS ester 2, 100mg

4,6-Dichloro-5-fluoronicotinic acid, 97.0%, 25g

(S)-1-tert-Butyl 2-ethyl 4-oxopiperidine-1,2-dicarboxylate, 95.0%, 500mg

3-Bromo-5-chloro-2-methylpyridine, 95.0%, 1g

2-Methoxy-3-methylisonicotinic acid, 95.0%, 500mg

CDTA, min 99%, pour synthèse, 500 g, emballage plastique.

2-Hydroxymethylbenzothiazole, 97.0%, 5g

1-Methoxy-4-vinylbenzene, 95.0%, 500g

1-[1-(phenoxymethyl)cyclopropyl]methanamine, 95.0%, 1g